Swiss Pharmaceuticals & Biotech Insider-Bought Value Plays

Idorsia

Market Cap: CHF 1.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.